| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus epidermidis (clinical isolate + methicillin-susceptible) |
1 |
4 |
0.25 － 16 |
Teicoplanin (Targocid)  |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-susceptible) |
1 |
4 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
1 － ? |
Bac2A-NH2 (Peptide) |
96 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
2 － ? |
CP-10A (Peptide) |
96 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
4 － ? |
Indolicidin |
96 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
8 － ? |
CP-11CN (Peptide) |
96 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
8 － ? |
RRP9W4N |
1361 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
16 － ? |
CP29 |
96 |
| Staphylococcus epidermidis (clinical isolate) |
- |
- |
32 － ? |
CP26 |
96 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
0.03 |
0.06 |
≤0.03 － 0.12 |
Retapamulin |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
0.25 |
0.5 |
≤0.25 － 1 |
Tiamulin (Tiamuline, Tiamutilin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
0.5 |
1 |
0.25 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
0.5 |
2 |
≤0.25 － >32 |
Cephalothin (Cefalotin, Keflin, Seffin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
>2 |
>2 |
≤0.03 － >2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
>2 |
>2 |
≤0.25 － >2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
2 |
30 |
≤0.12 － >30 |
Gentamicin (Gentamycin, Garamycin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
>4 |
>4 |
0.25 － >4 |
Bacitracin (Baci-IM) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
>30 |
>30 |
≤0.12 － >30 |
Ofloxacin (Floxin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
>100 |
>100 |
≤0.12 － >100 |
Clindamycin (Cleocin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-resistant) |
>200 |
>200 |
≤0.12 － >200 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.03 |
0.06 |
≤0.03 － 0.25 |
Retapamulin |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.12 |
≤0.12 |
≤0.12 － >100 |
Clindamycin (Cleocin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.12 － 4 |
Gentamicin (Gentamycin, Garamycin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>0.12 |
>200 |
≤0.12 － >200 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － 0.5 |
Cephalothin (Cefalotin, Keflin, Seffin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.25 |
0.5 |
≤0.12 － 8 |
Ofloxacin (Floxin) |
592 |
| Staphylococcus epidermidis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.25 |
0.5 |
≤0.25 － 2 |
Tiamulin (Tiamuline, Tiamutilin) |
592 |